Skip to main content
Susan Bates, MD, Oncology, New York, NY, New York-Presbyterian Hospital

SusanElaineBatesMD

Oncology New York, NY

Division of Hematology/Oncology, Columbia University Medical Center. Senior Investigator, Medical Oncology Branch and Affiliates, National Cancer Institute

Overview of Dr. Bates

Dr. Susan Bates is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and James J. Peters Veterans Affairs Medical Center. She received her medical degree from University of Arkansas for Medical Sciences (UAMS) College of Medicine and has been in practice 43 years. She is one of 369 doctors at New York-Presbyterian Hospital and one of 10 doctors at James J. Peters Veterans Affairs Medical Center who specialize in Oncology. She has more than 100 publications and over 500 citings.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1982 - 1984
  • University of Arkansas for Medical Sciences (UAMS) College of Medicine
    University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 1978 - 1980
  • University of Arkansas For Medical Sciences College of Medicine
    University of Arkansas For Medical Sciences College of MedicineClass of 1978

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2022 - 2025
  • AR State Medical License
    AR State Medical License 1978 - 2024
  • NY State Medical License
    NY State Medical License 2015 - 2024
  • MD State Medical License
    MD State Medical License 1985 - 2018
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Editor in Chief The Oncologist, 2022

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Clinical Trials in Pancreatic Cancer: A Long Slog  
    Susan Bates, MD, The Oncologist

Authored Content

  • Epidermal Growth Factor Receptor (EGFR) Inhibitor PD153035 Reverses ABCG2-Mediated Multidrug Resistance in Non-Small Cell Lung Cancer: In Vitro and in VivoMarch 2018

Press Mentions

  • ORIGINAL ARTICLE Bioengineered miR-27b-3p and miR-328-3p Modulate Drug Metabolism and Disposition via the Regulation of Target ADME Gene Expression
    ORIGINAL ARTICLE Bioengineered miR-27b-3p and miR-328-3p Modulate Drug Metabolism and Disposition via the Regulation of Target ADME Gene ExpressionMay 16th, 2019
  • Susan Bates, M.D., and Antonio “Tito” Fojo, M.D., Ph.D.: Thirty Years of Research, Discovery, Service, and Mentorship at the National Cancer Institute
    Susan Bates, M.D., and Antonio “Tito” Fojo, M.D., Ph.D.: Thirty Years of Research, Discovery, Service, and Mentorship at the National Cancer InstituteNovember 4th, 2015

Grant Support

  • Translational Studies Of The Histone Deacetylase Inhibitor RomidepsinNational Cancer Institute2010–2011
  • Investigation Of The ABC Half-Transporter ABCG2National Cancer Institute2010–2011
  • Clinical Studies To Circumvent Drug ResistanceNational Cancer Institute2010–2011
  • Translational Studies Of The Histone Deacetylase Inhibitor RomidepsinDivision Of Basic Sciences - Nci2009
  • Investigation Of The ABC Half-Transporter ABCG2Division Of Basic Sciences - Nci2009
  • Clinical Studies To Circumvent Drug ResistanceDivision Of Basic Sciences - Nci2009
  • Translational Studies Of The Histone Deacetylase Inhibitor RomidepsinNational Cancer Institute2008
  • Investigation Of The ABC Half-Transporter ABCG2National Cancer Institute2008
  • Clinical Studies Of Multidrug Resistance ReversalNational Cancer Institute2007–2008
  • III. Investigation Of The ABC Half-Transporter ABCG2National Cancer Institute2007
  • II. Clinical And Laboratory Studies Of The Histone Deacetylase Inhibitor DepsipeNational Cancer Institute2007
  • Investigation Of The ABC Half-Transporter ABCG2Division Of Basic Sciences - Nci2006
  • Clinical And Laboratory Studies Of The Histone DeacetylaDivision Of Basic Sciences - Nci2006
  • Clinical Studies Of Multidrug Resistance ReversalDivision Of Basic Sciences - Nci2004–2006
  • II. Clinical And Laboratory Studies Of The Histone DeaceDivision Of Basic Sciences - Nci2005
  • III. Investigation Of The ABC Half-Transporter ABCG2Division Of Basic Sciences - Nci2004–2005
  • Histone Deacetylase Inhibitor DepsipeptideDivision Of Basic Sciences - Nci2004

Professional Memberships

Hospital Affiliations